GlaxoSmithkline Consumer Healthcare has informed that the Board of Directors of the Company at its meeting held on May 11, 2017, has recommended a Dividend at the rate of Rs 70 per equity share of Rs 10 each. The dividend shall be paid to the entitled Members on or before September 08, 2017.
The above information is a part of company’s filings submitted to BSE.